Putnam Global Health Care R (PHSRX)
| Fund Assets | 1.38B |
| Expense Ratio | 1.30% |
| Min. Investment | $500 |
| Turnover | 36.00% |
| Dividend (ttm) | 2.69 |
| Dividend Yield | 5.33% |
| Dividend Growth | -14.40% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 23, 2024 |
| Previous Close | 50.16 |
| YTD Return | 2.14% |
| 1-Year Return | -12.79% |
| 5-Year Return | 37.52% |
| 52-Week Low | 46.18 |
| 52-Week High | 61.53 |
| Beta (5Y) | n/a |
| Holdings | 91 |
| Inception Date | Jan 21, 2003 |
About PHSRX
Putnam Global Health Care Fund Class R is a mutual fund focused on the global health care sector. Its primary objective is capital appreciation by investing predominantly in common stocks of large and mid-sized companies worldwide that operate within the medical and health-care industries. The portfolio covers a broad range of areas, including pharmaceutical firms, medical-device manufacturers, biotechnology companies, service providers like HMOs and hospitals, as well as nursing homes. The fund leverages a combination of fundamental research and technical analysis, with active monitoring of scientific advancements and regulatory shifts that impact the sector. Managed by Michael Maguire since 2016, it seeks to capture growth opportunities driven by innovation and demographic trends in the global health sector. The fund's holdings are notably concentrated, with over half of its assets in its top ten positions, reflecting a targeted rather than highly diversified approach. Putnam Global Health Care Fund Class R serves investors seeking focused exposure to the dynamic and essential health care industry, which plays a critical role in both developed and emerging markets.
Performance
PHSRX had a total return of -12.79% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.76%.
Top 10 Holdings
52.96% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 10.17% |
| AbbVie Inc. | ABBV | 6.51% |
| Johnson & Johnson | JNJ | 6.20% |
| AstraZeneca PLC | AZN | 5.26% |
| Thermo Fisher Scientific Inc. | TMO | 4.80% |
| Boston Scientific Corporation | BSX | 4.39% |
| Abbott Laboratories | ABT | 4.21% |
| Novartis AG | NOVN | 4.18% |
| Merck & Co., Inc. | MRK | 3.94% |
| UnitedHealth Group Incorporated | UNH | 3.30% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2024 | $2.692 | Dec 26, 2024 |
| Dec 21, 2023 | $3.145 | Dec 26, 2023 |
| Dec 22, 2022 | $4.379 | Dec 27, 2022 |
| Dec 22, 2021 | $7.390 | Dec 27, 2021 |
| Dec 23, 2020 | $5.499 | Dec 28, 2020 |
| Dec 23, 2019 | $3.127 | Dec 26, 2019 |